G. Negretto

Oxidative stress in Niemann-Pick type C patients: a protective role of N-butyl-deoxynojirimycin therapy

C. Vargas, M. Wajner, G. Ribas, 2012, International Journal of Developmental Neuroscience.

Glycosaminoglycans can be associated with oxidative damage in mucopolysaccharidosis II patients submitted to enzyme replacement therapy

C. Vargas, R. Giugliani, G. Biancini, 2014, Cell Biology and Toxicology.

In vitro effect of genistein on DNA damage in leukocytes from mucopolysaccharidosis IVA patients.

C. Vargas, R. Giugliani, S. Garcia, 2014, Molecular genetics and metabolism.

Glycosaminoglycans can be associated with oxidative damage in mucopolysaccharidosis II patients submitted to enzyme replacement therapy

C. Vargas, R. Giugliani, G. Biancini, 2014, Cell Biology and Toxicology.

Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiency

C. Vargas, M. Wajner, T. Derks, 2014, Journal of Inherited Metabolic Disease.

USE OF WARFARIN IN PEDIATRICS: CLINICAL AND PHARMACOLOGICAL CHARACTERISTICS

G. Negretto, Bruna Santos, I. Heineck, 2017, Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo.

The pharmaceutical care bundle: development and evaluation of an instrument for inpatient monitoring

G. Negretto, J. Zuckermann, B. S. D. Rocha, 2021, Clinical & Biomedical Research.

Oxidative stress in Niemann-Pick type C patients: a protective role of N-butyl-deoxynojirimycin therapy

C. Vargas, M. Wajner, G. Ribas, 2012, International Journal of Developmental Neuroscience.